IDEAS home Printed from https://ideas.repec.org/f/pha1219.html
   My authors  Follow this author

Grace Hampson

Personal Details

First Name:Grace
Middle Name:
Last Name:Hampson
Suffix:
RePEc Short-ID:pha1219

Affiliation

Office of Health Economics

London, United Kingdom
http://www.ohe.org/

: +44 (0) 20 7747 1440
+44 (0) 20 7691 7355
Southside, 7th Floor, 105 Victoria Street, London SW1E 6QT
RePEc:edi:ohecouk (more details at EDIRC)

Research output

as
Jump to: Working papers Articles

Working papers

  1. Hampson, G. & Mott, D. & Devlin, N. & Shah, K., 2019. "Public Preferences for Health Gains and Cures: A Discrete Choice Experiment," Consulting Reports 002108, Office of Health Economics.
  2. Pearson, S. & Dreitlein, B. & Towse, A. & Hampson, G. & Henshall, C., 2018. "Understanding the Context, Selecting the Standards: A Framework to Guide the Optimal Development and Use of Real-World Evidence for Coverage and Formulary Decisions," Research Papers 001998, Office of Health Economics.
  3. Hampson, G. & Towse, A. & Dreitlein, B. & Henshall, C. & Pearson, S., 2018. "Real World Evidence for Coverage Decisions: Opportunities and Challenges," Research Papers 001997, Office of Health Economics.
  4. Barnsley, P. & Hampson, G. & Towse, A. & Henshall, C., 2017. "Transferability of HTA," Briefings 001837, Office of Health Economics.
  5. Maignen, F. & Berdud, M. & Hampson, G. & Lorgelly, P., 2017. "Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market," Consulting Reports 001933, Office of Health Economics.
  6. Hampson, G. & Towse, A. & Henshall, C., 2017. "How can HTA meet the needs of health system and government decision makers?," Briefings 001836, Office of Health Economics.
  7. Hampson, G. & Lichten, C. & Berdud, M. & Pollitt, A. & Mestre-Ferrandiz, J. & Sussex, J. & Towse, A., 2017. "'Macro' Evaluation of the NIHR Oxford Biomedical Research Centre," Research Papers 001848, Office of Health Economics.
  8. Marsden, G. & Towse, A. & Pearson, S.D & Dreitlein, B. & Henshall, C., 2017. "Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value," Research Papers 001811, Office of Health Economics.
  9. Hampson, G. & Towse, A. & Henshall, C., 2017. "Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies," Briefings 001835, Office of Health Economics.
  10. Marsden, G. & Towse, A., 2017. "Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?," Consulting Reports 001802, Office of Health Economics.
  11. Marsden, G. & Martin, A. & Zamora, B. & Exley, J. & Sussex, J. & Towse, A., 2016. "Four Case Studies to Explore the Added Value of Oxford AHSN," Consulting Reports 001743, Office of Health Economics.
  12. Cole, A. & Marsden, G. & Devlin, N. & Grainger, D. & Lee, E.K & Oortwijn, W., 2016. ""New Age" Decision Making in HTA: Is It Applicable in Asia?," Briefings 001741, Office of Health Economics.
  13. Brockis, E. & Marsden, G. & Cole, A. & Devlin, N., 2016. "A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications," Research Papers 001703, Office of Health Economics.
  14. Garau, M. & Marsden, G. & Devlin, N. & Amedeo Mazzanti, N. & Profico, A., 2016. "Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders' Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)," Research Papers 001773, Office of Health Economics.
  15. Marsden, G. & Mestre-Ferrandiz, J., 2015. "Dementia: The R&D Landscape," Research Papers 001657, Office of Health Economics.

Articles

  1. Bengt Jönsson & Grace Hampson & Jonathan Michaels & Adrian Towse & J.-Matthias Graf Schulenburg & Olivier Wong, 2019. "Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 427-438, April.
  2. Martina Garau & Grace Hampson & Nancy Devlin & Nicola Amedeo Mazzanti & Antonio Profico, 2018. "Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)," PharmacoEconomics - Open, Springer, vol. 2(2), pages 153-163, June.
  3. Emma Cowles & Grace Marsden & Amanda Cole & Nancy Devlin, 2017. "A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact?," Applied Health Economics and Health Policy, Springer, vol. 15(4), pages 469-477, August.
  4. Yan Feng & Toby Watt & Anita Charlesworth & Grace Marsden & Adam Roberts & Jon Sussex, 2017. "What Determines the Health Care Expenditure of High Income Countries? A Dynamic Estimation," Applied Economics and Finance, Redfame publishing, vol. 4(6), pages 1-16, November.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Hampson, G. & Towse, A. & Dreitlein, B. & Henshall, C. & Pearson, S., 2018. "Real World Evidence for Coverage Decisions: Opportunities and Challenges," Research Papers 001997, Office of Health Economics.

    Cited by:

    1. Jorge Mestre-Ferrandiz & Néboa Zozaya & Bleric Alcalá & Álvaro Hidalgo-Vega, 2018. "Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?," PharmacoEconomics, Springer, vol. 36(12), pages 1407-1420, December.

  2. Barnsley, P. & Hampson, G. & Towse, A. & Henshall, C., 2017. "Transferability of HTA," Briefings 001837, Office of Health Economics.

    Cited by:

    1. Hampson, G. & Towse, A. & Henshall, C., 2017. "Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies," Briefings 001835, Office of Health Economics.

  3. Marsden, G. & Towse, A. & Pearson, S.D & Dreitlein, B. & Henshall, C., 2017. "Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value," Research Papers 001811, Office of Health Economics.

    Cited by:

    1. Hanna, E. & Toumi, M. & Dussart, C. & Borissov, B. & Dabbous, O. & Badora, K. & Auquier, P., 2018. "Funding breakthrough therapies: A systematic review and recommendation," Health Policy, Elsevier, vol. 122(3), pages 217-229.
    2. Bengt Jönsson & Grace Hampson & Jonathan Michaels & Adrian Towse & J.-Matthias Graf Schulenburg & Olivier Wong, 2019. "Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 427-438, April.

  4. Marsden, G. & Towse, A., 2017. "Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?," Consulting Reports 001802, Office of Health Economics.

    Cited by:

    1. Hampson, G. & Mott, D. & Devlin, N. & Shah, K., 2019. "Public Preferences for Health Gains and Cures: A Discrete Choice Experiment," Consulting Reports 002108, Office of Health Economics.
    2. Bengt Jönsson & Grace Hampson & Jonathan Michaels & Adrian Towse & J.-Matthias Graf Schulenburg & Olivier Wong, 2019. "Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 427-438, April.

  5. Brockis, E. & Marsden, G. & Cole, A. & Devlin, N., 2016. "A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications," Research Papers 001703, Office of Health Economics.

    Cited by:

    1. Petra Marešová & Lukáš Peter & Jan Honegr & Lukáš Režný & Marek Penhaker & Martin Augustýnek & Hana Mohelská & Blanka Klímová & Kamil Kuča, 2020. "Complexity Stage Model of the Medical Device Development Based on Economic Evaluation—MedDee," Sustainability, MDPI, Open Access Journal, vol. 12(5), pages 1-27, February.
    2. Fernando Antoñanzas & Robert Terkola & Paul M. Overton & Natalie Shalet & Maarten Postma, 2017. "Defining and Measuring the Affordability of New Medicines: A Systematic Review," PharmacoEconomics, Springer, vol. 35(8), pages 777-791, August.

Articles

  1. Emma Cowles & Grace Marsden & Amanda Cole & Nancy Devlin, 2017. "A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact?," Applied Health Economics and Health Policy, Springer, vol. 15(4), pages 469-477, August.

    Cited by:

    1. Eve Wittenberg & Lyndon P. James & Lisa A. Prosser, 2019. "Spillover Effects on Caregivers’ and Family Members’ Utility: A Systematic Review of the Literature," PharmacoEconomics, Springer, vol. 37(4), pages 475-499, April.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 9 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-HEA: Health Economics (8) 2018-05-14 2018-05-21 2018-05-21 2018-05-21 2018-05-21 2018-05-21 2018-05-21 2019-02-04. Author is listed
  2. NEP-SEA: South East Asia (3) 2018-05-21 2018-05-21 2018-05-21. Author is listed
  3. NEP-DCM: Discrete Choice Models (1) 2019-02-04
  4. NEP-ENE: Energy Economics (1) 2018-05-28
  5. NEP-ENV: Environmental Economics (1) 2018-05-28
  6. NEP-EUR: Microeconomic European Issues (1) 2018-05-21
  7. NEP-IAS: Insurance Economics (1) 2018-05-21
  8. NEP-INT: International Trade (1) 2018-05-21
  9. NEP-PPM: Project, Program & Portfolio Management (1) 2018-05-28

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Grace Hampson should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.